A general homogeneous hydrogen isotope labelling strategy for unactivated alkyl halides is reported. This approach overcomes the limited selectivity of traditional methods by combining bioinspired carbon–halogen activation and hydrogenation catalysis, enabling the selective and controlled synthesis of deuterium- and tritium-labelled drug molecules, which are crucial for drug discovery.
- Beibei Zhang
- Zhenyang Zhang
- Da Zhao